
Sign up to save your podcasts
Or


In this episode, Anthony and Bernie are joined once again by special guest and hematology expert, Dr. Dale Bixby, to discuss the recent publication of the QUANTUM-First study of quizartinib in newly diagnosed AML. Should this study change practice in FLT3-ITD+ AML? Have we made a "Quantum Leap" in the treatment of these patients? Listen for a fun-filled discussion of the data!
Notable References:
By Bernard Marini, Anthony Perissinotti, et al.4.5
2828 ratings
In this episode, Anthony and Bernie are joined once again by special guest and hematology expert, Dr. Dale Bixby, to discuss the recent publication of the QUANTUM-First study of quizartinib in newly diagnosed AML. Should this study change practice in FLT3-ITD+ AML? Have we made a "Quantum Leap" in the treatment of these patients? Listen for a fun-filled discussion of the data!
Notable References:

498 Listeners

28 Listeners

184 Listeners

8,187 Listeners

2 Listeners

756 Listeners

12 Listeners

53 Listeners

57 Listeners

136 Listeners

1 Listeners

49 Listeners

185 Listeners

43 Listeners

3 Listeners